$THMO
ThermoGenesis Holdings, Inc.

2017 Q2 Form 10-K Financial Statement

#000143774917016219 Filed on September 22, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2017 2016 Q2
Revenue $3.501M $14.53M $2.980M
YoY Change 17.48% 21.76% -19.46%
Cost Of Revenue $1.973M $8.686M $2.040M
YoY Change -3.28% -5.43% -27.66%
Gross Profit $1.528M $5.839M $940.0K
YoY Change 62.55% 112.79% 6.82%
Gross Profit Margin 43.64% 40.2% 31.54%
Selling, General & Admin $2.384M $12.40M $2.400M
YoY Change -0.67% 19.48% 16.5%
% of Gross Profit 156.02% 212.38% 255.32%
Research & Development $566.0K $2.497M $780.0K
YoY Change -27.44% -22.69% -35.54%
% of Gross Profit 37.04% 42.76% 82.98%
Depreciation & Amortization $172.0K $830.0K $290.0K
YoY Change -40.69% -28.94% -14.71%
% of Gross Profit 11.26% 14.21% 30.85%
Operating Expenses $3.260M $15.21M $3.180M
YoY Change 2.52% 11.75% -2.75%
Operating Profit -$1.732M -$9.369M -$2.240M
YoY Change -22.68% -13.77% -6.28%
Interest Expense $112.0K $20.52M -$470.0K
YoY Change -123.83% 1000.8% -4800.0%
% of Operating Profit
Other Income/Expense, Net -$95.00K -$20.53M -$980.0K
YoY Change -90.31% 165.8%
Pretax Income -$1.827M -$29.77M -$3.690M
YoY Change -50.49% 60.15% 55.04%
Income Tax -$673.0K -$673.0K
% Of Pretax Income
Net Earnings -$1.154M -$29.10M -$3.690M
YoY Change -68.73% 56.53% 55.04%
Net Earnings / Revenue -32.96% -200.31% -123.83%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.162M -$2.257M -$12.30M
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q2 2017 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.620M $3.510M $5.840M
YoY Change -38.01% -39.9% 73.81%
Cash & Equivalents $3.623M $3.510M $5.835M
Short-Term Investments
Other Short-Term Assets $240.0K $590.0K $250.0K
YoY Change -4.0% 136.0% 56.25%
Inventory $3.617M $4.800M $3.593M
Prepaid Expenses
Receivables $3.701M $2.550M $3.169M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $11.18M $11.45M $12.84M
YoY Change -12.96% -10.83% -3.08%
LONG-TERM ASSETS
Property, Plant & Equipment $2.330M $3.000M $2.962M
YoY Change -21.34% 1.35% 0.85%
Goodwill $13.20M $13.20M
YoY Change 0.0% 0.0%
Intangibles $20.17M $20.82M
YoY Change -3.15% -2.23%
Long-Term Investments
YoY Change
Other Assets $64.00K $1.060M $78.00K
YoY Change -17.95% 1225.0% -1.27%
Total Long-Term Assets $35.75M $39.66M $37.06M
YoY Change -3.51% 7.02% -1.2%
TOTAL ASSETS
Total Short-Term Assets $11.18M $11.45M $12.84M
Total Long-Term Assets $35.75M $39.66M $37.06M
Total Assets $46.93M $51.11M $49.90M
YoY Change -5.95% 2.42% -1.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.601M $2.080M $2.648M
YoY Change -39.54% -21.51% -47.86%
Accrued Expenses $390.0K $530.0K $450.0K
YoY Change -13.33% 17.78% -36.62%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.520M $5.460M $5.542M
YoY Change -18.44% -1.44% -30.25%
LONG-TERM LIABILITIES
Long-Term Debt $3.500M $6.700M $2.490M
YoY Change 40.56% 169.08%
Other Long-Term Liabilities $377.0K $1.010M $1.284M
YoY Change -70.64% -48.21% 379.1%
Total Long-Term Liabilities $377.0K $7.710M $1.284M
YoY Change -70.64% 73.65% 379.1%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.520M $5.460M $5.542M
Total Long-Term Liabilities $377.0K $7.710M $1.284M
Total Liabilities $16.10M $17.41M $17.63M
YoY Change -8.69% -1.25% 11.17%
SHAREHOLDERS EQUITY
Retained Earnings -$185.4M -$156.3M
YoY Change 18.62% 13.5%
Common Stock $10.00K $3.000K
YoY Change 233.33% 50.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $30.84M $33.70M $32.27M
YoY Change
Total Liabilities & Shareholders Equity $46.93M $51.11M $49.90M
YoY Change -5.95% 2.42% -1.69%

Cashflow Statement

Concept 2017 Q2 2017 2016 Q2
OPERATING ACTIVITIES
Net Income -$1.154M -$29.10M -$3.690M
YoY Change -68.73% 56.53% 55.04%
Depreciation, Depletion And Amortization $172.0K $830.0K $290.0K
YoY Change -40.69% -28.94% -14.71%
Cash From Operating Activities -$2.110M -$7.215M -$1.280M
YoY Change 64.84% -25.04% -3.76%
INVESTING ACTIVITIES
Capital Expenditures -$70.00K $375.0K -$110.0K
YoY Change -36.36% -47.18% 120.0%
Acquisitions
YoY Change
Other Investing Activities -$1.000M
YoY Change
Cash From Investing Activities -$70.00K -$375.0K -$110.0K
YoY Change -36.36% -47.18% 120.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$1.958M
YoY Change -20.24%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.990M 5.374M -30.00K
YoY Change -6733.33% -58.09% -40.0%
NET CHANGE
Cash From Operating Activities -2.110M -7.215M -1.280M
Cash From Investing Activities -70.00K -375.0K -110.0K
Cash From Financing Activities 1.990M 5.374M -30.00K
Net Change In Cash -190.0K -2.212M -1.420M
YoY Change -86.62% -188.87% -0.7%
FREE CASH FLOW
Cash From Operating Activities -$2.110M -$7.215M -$1.280M
Capital Expenditures -$70.00K $375.0K -$110.0K
Free Cash Flow -$2.040M -$7.590M -$1.170M
YoY Change 74.36% -26.56% -8.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017 dei Amendment Flag
AmendmentFlag
false
CY2017 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2017 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017 dei Document Period End Date
DocumentPeriodEndDate
2017-06-30
CY2017 dei Document Type
DocumentType
10-K
CY2016Q4 dei Entity Public Float
EntityPublicFloat
10334000
CY2015Q3 kool Approval For Grant In Amount For Clinical Trial
ApprovalForGrantInAmountForClinicalTrial
10000000
CY2017 kool Deferred Income Tax Benefit Due To Prior Years State Rate Changes
DeferredIncomeTaxBenefitDueToPriorYearsStateRateChanges
-559000
CY2016 kool Deferred Income Tax Benefit Due To Prior Years State Rate Changes
DeferredIncomeTaxBenefitDueToPriorYearsStateRateChanges
-157000
CY2015 kool Deferred Income Tax Benefit Due To Prior Years State Rate Changes
DeferredIncomeTaxBenefitDueToPriorYearsStateRateChanges
-402000
CY2017 kool Derivative Obligation Related To Issuance Of Warrants
DerivativeObligationRelatedToIssuanceOfWarrants
CY2016 kool Derivative Obligation Related To Issuance Of Warrants
DerivativeObligationRelatedToIssuanceOfWarrants
4282000
CY2017 kool Effective Income Tax Rate Reconciliation Disallowed Financing Costs Amount
EffectiveIncomeTaxRateReconciliationDisallowedFinancingCostsAmount
6959000
CY2016 kool Effective Income Tax Rate Reconciliation Disallowed Financing Costs Amount
EffectiveIncomeTaxRateReconciliationDisallowedFinancingCostsAmount
2607000
CY2017 kool Effective Income Tax Rate Reconciliation Unbenefitted Net Operating Losses And Credits Amount
EffectiveIncomeTaxRateReconciliationUnbenefittedNetOperatingLossesAndCreditsAmount
2281000
CY2016 kool Effective Income Tax Rate Reconciliation Unbenefitted Net Operating Losses And Credits Amount
EffectiveIncomeTaxRateReconciliationUnbenefittedNetOperatingLossesAndCreditsAmount
3391000
CY2017 kool Gain Loss On Cashless Exercise Of Warrants
GainLossOnCashlessExerciseOfWarrants
CY2016 kool Gain Loss On Cashless Exercise Of Warrants
GainLossOnCashlessExerciseOfWarrants
-1039000
CY2017 kool Gain Losses On Warrant Modifications
GainLossesOnWarrantModifications
CY2016 kool Gain Losses On Warrant Modifications
GainLossesOnWarrantModifications
-149000
CY2017 kool Inventory Change In Reserve
InventoryChangeInReserve
-203000
CY2016 kool Inventory Change In Reserve
InventoryChangeInReserve
566000
CY2017 kool Maximum Period Of Agreement
MaximumPeriodOfAgreement
P21Y
CY2017 kool Number Of Suppliers
NumberOfSuppliers
2
CY2016 kool Number Of Suppliers
NumberOfSuppliers
2
CY2017 kool Payment Terms Severance Compensation
PaymentTermsSeveranceCompensation
P1Y
CY2017Q2 kool Short Term Investment Minimum
ShortTermInvestmentMinimum
2000000
CY2017 kool Stock Issued During Period Value Prior Year Bonus
StockIssuedDuringPeriodValuePriorYearBonus
204000
CY2017Q2 kool Tax Benefits Related To Stock Options Included In Valuation Allowance
TaxBenefitsRelatedToStockOptionsIncludedInValuationAllowance
215000
CY2017 kool Transfer Of Equipment To Inventories
TransferOfEquipmentToInventories
625000
CY2016 kool Transfer Of Equipment To Inventories
TransferOfEquipmentToInventories
CY2017Q2 kool Working Capital
WorkingCapital
6658000
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1601000
CY2016Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2648000
CY2017Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3701000
CY2016Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3169000
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4829000
CY2016Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4448000
CY2017Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-38000
CY2016Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-37000
CY2017Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
216222000
CY2016Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
188569000
CY2016 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
7262000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
710000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1445000
CY2016 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
4434000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1461000
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
742000
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
102000
CY2016Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
49000
CY2017 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
9851000
CY2016 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
6127000
CY2017 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
160000
CY2016 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
800000
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9915868
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3010687
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9915868
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3010687
CY2017 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
9851000
CY2016 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
6127000
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
359000
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
438000
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5285805
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8673138
CY2017Q2 us-gaap Assets
Assets
46932000
CY2016Q2 us-gaap Assets
Assets
49899000
CY2017Q2 us-gaap Assets Current
AssetsCurrent
11178000
CY2016Q2 us-gaap Assets Current
AssetsCurrent
12843000
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3623000
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5835000
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3357000
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2212000
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2478000
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
10000
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
3000
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-29096000
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18620000
CY2017 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Credit Risk</div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Currently, the Company primarily manufactures and sells cellular processing systems and thermodynamic devices principally to the blood and cellular component processing industry and performs ongoing evaluations of the credit worthiness of the Company&#x2019;s customers. The Company believes that adequate </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">provisions for uncollectible accounts have been made in the accompanying consolidated financial statements. To date, the Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> experienced significant credit related losses.</div></div></div></div></div></div>
CY2017Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
CY2016Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
2489000
CY2017 us-gaap Cost Of Revenue
CostOfRevenue
8686000
CY2016 us-gaap Cost Of Revenue
CostOfRevenue
9185000
CY2016Q3 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
6102941
CY2016Q3 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
23903000
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-673000
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
CY2017Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
7144000
CY2016Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
7871000
CY2017Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
597000
CY2016Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
783000
CY2017Q2 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
1047000
CY2016Q2 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
874000
CY2017Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
48277000
CY2016Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
46122000
CY2017Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
43687000
CY2016Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
41023000
CY2017Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1124000
CY2016Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1858000
CY2017Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
2419000
CY2016Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
2367000
CY2017Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
48101000
CY2016Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
45892000
CY2017Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
6968000
CY2016Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
7641000
CY2017Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
6968000
CY2016Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
7641000
CY2017Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
6968000
CY2016Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
7641000
CY2017Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
176000
CY2016Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
230000
CY2017 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
0
CY2016 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
0
CY2017 us-gaap Depreciation
Depreciation
408000
CY2016 us-gaap Depreciation
Depreciation
630000
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
830000
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1168000
CY2017 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-60000
CY2016 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
3395000
CY2016Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
670000
CY2017Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
730000
CY2017Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
606000
CY2016Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
CY2017Q2 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
3500000
CY2016Q2 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.27
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-7.57
CY2017 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
4000
CY2016 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-11000
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2017Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
385000
CY2016Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
449000
CY2016 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
CY2017Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1395000
CY2016Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1005000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
81000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
52000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
81000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
81000
CY2017Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2000000
CY2016Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1956000
CY2017Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
295000
CY2016Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
951000
CY2017 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-176000
CY2016 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
CY2017 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
CY2016 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-795000
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11051000
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8231000
CY2017Q2 us-gaap Goodwill
Goodwill
13195000
CY2016Q2 us-gaap Goodwill
Goodwill
13195000
CY2017 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2017 us-gaap Gross Profit
GrossProfit
5839000
CY2016 us-gaap Gross Profit
GrossProfit
2744000
CY2017 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
310000
CY2016 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
29005000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-17789000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29768000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18588000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-763000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-799000
CY2017Q2 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-673000
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-10121000
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-6300000
CY2017 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
120000
CY2016 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
233000
CY2017 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
88000
CY2016 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
69000
CY2017 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1062000
CY2016 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-2420000
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
522000
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1956000
CY2017 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-187000
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
148000
CY2017 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
606000
CY2016 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
CY2017 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-63000
CY2016 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-256000
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-615000
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-375000
CY2017 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
26000
CY2016 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
160000
CY2017 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
98000
CY2016 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
64000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-24000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
86000
CY2017Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
21870000
CY2016Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
21826000
CY2017Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20165000
CY2016Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20821000
CY2017 us-gaap Interest Expense
InterestExpense
10668000
CY2016 us-gaap Interest Expense
InterestExpense
1864000
CY2017Q2 us-gaap Inventory Net
InventoryNet
3617000
CY2016Q2 us-gaap Inventory Net
InventoryNet
3593000
CY2016 us-gaap Operating Expenses
OperatingExpenses
13609000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-9240000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-10865000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
579000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
297000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
3000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
279000
CY2017Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1230000
CY2016Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1437000
CY2017Q2 us-gaap Liabilities
Liabilities
16095000
CY2016Q2 us-gaap Liabilities
Liabilities
17626000
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
46932000
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49899000
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4520000
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5542000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5374000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12824000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-375000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-710000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7215000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9625000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-29095000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-18588000
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-20528000
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7723000
CY2017 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2017 us-gaap Operating Expenses
OperatingExpenses
15079000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
291000
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
657000
CY2017Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
64000
CY2016Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
78000
CY2017 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1000
CY2016 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-32000
CY2017 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1000
CY2016 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
18000000
CY2016Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2092000
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2092000
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2463000
CY2017 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
3500000
CY2016 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7159000
CY2016Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7410000
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2330000
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2962000
CY2016 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
32000
CY2016Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
566000
CY2015Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
627000
CY2017Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
588000
CY2017 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
93000
CY2017Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1331000
CY2016Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1662000
CY2017Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
377000
CY2016Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1284000
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
51000
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-44000
CY2017 us-gaap Paid In Kind Interest
PaidInKindInterest
10373000
CY2016 us-gaap Paid In Kind Interest
PaidInKindInterest
1031000
CY2017 us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
CY2016 us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
159000
CY2017 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
134000
CY2016 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
8000
CY2017 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
CY2016 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
961000
CY2016Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
369000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
375000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
710000
CY2017Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2016Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2017Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
237000
CY2016Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
246000
CY2017 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
CY2016 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
287000
CY2017 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-5000
CY2016 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
129000
CY2017 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
120000
CY2016 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
97000
CY2017 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
CY2016 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
1109000
CY2017 us-gaap Registration Payment Arrangement Gains And Losses
RegistrationPaymentArrangementGainsAndLosses
CY2016 us-gaap Registration Payment Arrangement Gains And Losses
RegistrationPaymentArrangementGainsAndLosses
-1100000
CY2017 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
CY2016 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
6444000
CY2017 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
84000
CY2016 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
67000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2497000
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3230000
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-156262000
CY2017 us-gaap Sales Revenue Net
SalesRevenueNet
14525000
CY2016 us-gaap Sales Revenue Net
SalesRevenueNet
11929000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.015
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.16
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.75
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-185357000
CY2016Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
4.10
CY2017 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1531000
CY2016 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2148000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
1461000
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
742000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.02
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.8
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.013
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y
CY2017 us-gaap Stock Issued1
StockIssued1
23903000
CY2016 us-gaap Stock Issued1
StockIssued1
CY2016Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
600000
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2017 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
23903000
CY2016 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
24000
CY2017 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
16000
CY2016 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2464000
CY2017 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2092000
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
30837000
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
32273000
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
34902000
CY2017Q2 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
1456000
CY2017Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2016Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are used for, but <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> limited to, the allowance for doubtful accounts, slow-moving inventory reserves, depreciation, warranty costs, assumptions made in valuing equity instruments issued for services or acquisitions, deferred income taxes and related valuation allowance and the fair values of intangibles and goodwill. Actual results could materially differ from the estimates and assumptions used in the preparation of the Company&#x2019;s consolidated financial statements. Events subsequent to the balance sheet date have been evaluated for inclusion in the accompanying consolidated financial statements through the date of issuance.</div></div></div></div></div></div>
CY2017 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
2209000
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8904508
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2455548

Files In Submission

Name View Source Status
0001437749-17-016219-index-headers.html Edgar Link pending
0001437749-17-016219-index.html Edgar Link pending
0001437749-17-016219.txt Edgar Link pending
0001437749-17-016219-xbrl.zip Edgar Link pending
ex10-29.htm Edgar Link pending
ex23-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kool-20170630.xml Edgar Link completed
kool-20170630.xsd Edgar Link pending
kool-20170630_cal.xml Edgar Link unprocessable
kool-20170630_def.xml Edgar Link unprocessable
kool-20170630_lab.xml Edgar Link unprocessable
kool-20170630_pre.xml Edgar Link unprocessable
kool20170630_10k.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending